SEAGULL HEALTH
Your health,We care!
Disitamab Vedotin for Injection is characterized by precise targeted tumor cell killing, significant efficacy in gastric cancer and urothelial carcinoma refractory to multiple lines of treatment, and a controllable safety profile.
AuthenticGuaranteeFast DeliveryPrivacy On June 9, 2021, the National Medical Products Administration (NMPA) granted conditional approval for the marketing of Disitamab Vedotin for Injection.
On June 9, 2021, the National Medical Products Administration (NMPA) granted conditional approval for Disitamab Vedotin for Injection (brand name: Aid···【Read More】
Update: 10 Feb,2026Source: Haiou HealthViews: 111
Copyright 2024 @ haiouhealth.com All right reserved Seagull health | Bigbear Pharmaceutical | Lucius Pharmaceuticals | 老挝全球药房
